U.S., Dec. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07274969) titled 'The Effect of Caffeine Therapy in Cardiovascular Stability in Preterm Neonates at Assiut University Children Hospital NICU' on Sept. 28.
Brief Summary: Preterm neonates younger than 37 weeks gestational age receiving caffeine therapy for apnea of prematurity in a NICU setting.
Study Start Date: June 30, 2026
Study Type: OBSERVATIONAL
Condition:
Preterm Neonates
Apnea of Prematurity
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Assiut University
Information provided by (Responsible Party): Margret Azer, Assiut University
Disclaimer: Curated by HT Syndication....